Related Experiment Video
Updated: Jan 3, 2026
06:31
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
3.0K
Osteoporosis in Rheumatic Diseases.
Giovanni Adami1, Angelo Fassio1, Maurizio Rossini1
1Rheumatology Unit, University of Verona, Policlinico Borgo Roma, Pz Scuro 10, 37134 Verona, Italy.
International Journal of Molecular Sciences
|November 27, 2019
Summary
Osteoporosis, a condition increasing fracture risk, disproportionately affects patients with rheumatic diseases. This review details osteoporosis
Area of Science:
- Rheumatology
- Endocrinology
- Bone Metabolism
Background:
- Osteoporosis is a chronic condition marked by heightened fragility fracture risk.
- Rheumatic diseases significantly elevate the risk of developing osteoporosis.
- Understanding this link is crucial for patient management.
Purpose of the Study:
- To comprehensively review osteoporosis in rheumatic disease patients.
- To focus on pathogenesis, epidemiology, and treatment strategies.
- To specifically examine rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, SLE, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.
Main Methods:
- Literature review of existing studies and clinical guidelines.
- Synthesis of data on disease mechanisms and risk factors.
- Analysis of current and emerging therapeutic interventions.
Main Results:
- Rheumatic diseases contribute to bone loss through inflammation, medication side effects, and reduced physical activity.
- Specific rheumatic conditions present unique osteoporosis profiles and challenges.
- Effective management requires a multi-faceted approach targeting both the rheumatic disease and osteoporosis.
Conclusions:
- Osteoporosis is a significant complication in rheumatic diseases, necessitating proactive screening and management.
- Tailored treatment strategies are essential for addressing the complex interplay between rheumatic conditions and bone health.
- Further research is needed to optimize osteoporosis prevention and treatment in this vulnerable patient population.
More Related Videos
Related Concept Videos
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:23Rheumatic Heart Disease I: Introduction
383
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
383
01:20Rheumatic Heart Disease IV: Nursing Management
231
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
231
01:31Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
417
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
417
01:21Rheumatic Heart Disease III: Medical Management
252
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
252